Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Safety and Immunogenicity Study of MYOBLOC (Neurobloc; Botulinum Toxin Type B) Injectable Solution in Patients With Cervical Dystonia

NCT00702754 is registered in ClinicalTrials.gov with Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC as lead sponsor.

NCT NCT00702754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00702754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Safety and Immunogenicity Study of MYOBLOC (Neurobloc; Botulinum Toxin Type B) Injectable Solution in Patients With Cervical Dystonia
Lead sponsor
Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2001
Completion date
September 30, 2008
Enrollment
502 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cervical dystonia